Exponent (EXPO) Competitors $69.31 +0.35 (+0.51%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$70.61 +1.30 (+1.88%) As of 10/24/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EXPO vs. FCN, VSEC, CBZ, HURN, ICFI, CRAI, ACTG, MG, FC, and OMEXShould you be buying Exponent stock or one of its competitors? The main competitors of Exponent include FTI Consulting (FCN), VSE (VSEC), CBIZ (CBZ), Huron Consulting Group (HURN), ICF International (ICFI), Charles River Associates (CRAI), Acacia Research (ACTG), Mistras Group (MG), Franklin Covey (FC), and Odyssey Marine Exploration (OMEX). These companies are all part of the "research & consulting services" industry. Exponent vs. Its Competitors FTI Consulting VSE CBIZ Huron Consulting Group ICF International Charles River Associates Acacia Research Mistras Group Franklin Covey Odyssey Marine Exploration FTI Consulting (NYSE:FCN) and Exponent (NASDAQ:EXPO) are both mid-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation. Do insiders & institutionals believe in FCN or EXPO? 99.4% of FTI Consulting shares are held by institutional investors. Comparatively, 92.4% of Exponent shares are held by institutional investors. 1.8% of FTI Consulting shares are held by insiders. Comparatively, 1.6% of Exponent shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has preferable earnings and valuation, FCN or EXPO? FTI Consulting has higher revenue and earnings than Exponent. FTI Consulting is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFTI Consulting$3.70B1.38$280.09M$7.1022.20Exponent$558.51M6.27$109M$2.0034.66 Is FCN or EXPO more profitable? Exponent has a net margin of 18.35% compared to FTI Consulting's net margin of 7.20%. Exponent's return on equity of 24.19% beat FTI Consulting's return on equity.Company Net Margins Return on Equity Return on Assets FTI Consulting7.20% 14.49% 8.38% Exponent 18.35%24.19%13.51% Does the media favor FCN or EXPO? In the previous week, FTI Consulting had 25 more articles in the media than Exponent. MarketBeat recorded 37 mentions for FTI Consulting and 12 mentions for Exponent. FTI Consulting's average media sentiment score of 0.67 beat Exponent's score of 0.30 indicating that FTI Consulting is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FTI Consulting 9 Very Positive mention(s) 6 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Exponent 4 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate FCN or EXPO? FTI Consulting presently has a consensus price target of $169.00, indicating a potential upside of 7.21%. Given FTI Consulting's stronger consensus rating and higher possible upside, analysts clearly believe FTI Consulting is more favorable than Exponent.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FTI Consulting 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Exponent 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, FCN or EXPO? FTI Consulting has a beta of 0.16, meaning that its share price is 84% less volatile than the S&P 500. Comparatively, Exponent has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. SummaryFTI Consulting beats Exponent on 10 of the 16 factors compared between the two stocks. Get Exponent News Delivered to You Automatically Sign up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EXPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXPO vs. The Competition Export to ExcelMetricExponentConsulting IndustryBusiness SectorNASDAQ ExchangeMarket Cap$3.50B$6.51B$26.96B$10.81BDividend Yield1.73%1.76%2.84%4.80%P/E Ratio34.6622.8423.9730.98Price / Sales6.272.81887.70133.64Price / Cash29.6416.3730.9661.86Price / Book8.365.367.746.61Net Income$109M$272.15M$197.91M$277.10M7 Day Performance2.68%1.85%5.37%2.57%1 Month Performance-0.27%-2.05%0.80%3.20%1 Year Performance-28.49%-6.88%49.45%33.22% Exponent Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXPOExponent2.9156 of 5 stars$69.31+0.5%N/A-28.5%$3.50B$558.51M34.661,168Trending NewsUpcoming EarningsAnalyst ForecastFCNFTI Consulting3.9436 of 5 stars$152.74+0.3%$175.50+14.9%-20.8%$4.93B$3.70B21.518,374Trending NewsEarnings ReportAnalyst ForecastBuyback AnnouncementAnalyst RevisionVSECVSE2.7454 of 5 stars$166.27+4.3%$175.67+5.7%+77.8%$3.30B$1.08B148.461,400News CoverageUpcoming EarningsAnalyst ForecastCBZCBIZ1.8805 of 5 stars$51.79+1.0%N/A-19.8%$2.77B$1.81B29.7610,000Upcoming EarningsAnalyst DowngradeHURNHuron Consulting Group3.7991 of 5 stars$151.80+2.5%$171.50+13.0%+47.9%$2.56B$1.52B26.497,230News CoveragePositive NewsUpcoming EarningsAnalyst ForecastICFIICF International4.1565 of 5 stars$90.72+2.9%$128.20+41.3%-46.4%$1.62B$2.02B15.789,300News CoverageUpcoming EarningsCRAICharles River Associates4.197 of 5 stars$182.98+1.4%$235.00+28.4%-0.5%$1.19B$687.41M22.15940Upcoming EarningsAnalyst ForecastACTGAcacia Research0.9343 of 5 stars$3.55+1.7%N/A-25.3%$336.59M$122.31M-59.161,036News CoverageAnalyst ForecastMGMistras Group3.8871 of 5 stars$9.81+3.2%N/A-6.5%$299.61M$729.64M26.504,800News CoverageUpcoming EarningsAnalyst ForecastFCFranklin Covey3.1007 of 5 stars$18.46+4.6%$27.00+46.3%-52.2%$223.13M$287.23M23.371,084OMEXOdyssey Marine ExplorationN/A$3.59-3.5%N/A+401.5%$168.34M$770K0.0010Positive NewsAnalyst Forecast Related Companies and Tools Related Companies FTI Consulting Alternatives VSE Alternatives CBIZ Alternatives Huron Consulting Group Alternatives ICF International Alternatives Charles River Associates Alternatives Acacia Research Alternatives Mistras Group Alternatives Franklin Covey Alternatives Odyssey Marine Exploration Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EXPO) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredA Worldwide Gold Lockdown Is Now UnderwayCentral banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman S...Stansberry Research | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis gold stock is STILL undervalued by 80%...“Like buying gold for $1,000/oz” If you could go back in time to 10+ years ago and buy gold for $1,000 an o...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exponent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exponent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
